Filling the need for trusted information on national health issues…

Trending on kff Open Enrollment Medicare Part D Medicaid Expansion

Kaiser Daily Global Health Policy ReportIntellectual Property and Trade Search Results « » The Henry J. Kaiser Family Foundation

Intellectual Property and Trade

  • your selections
Clear Search

Filter Results



  • results
In Current Form, TPP Could Fundamentally Harm U.S. Global Health Initiatives, Patients

The Hill: Don’t forget consumers and patients in the Trans-Pacific Partnership Nancy LeaMond, AARP’s chief advocacy and engagement officer, and Sophie Delaunay, executive director of Doctors Without Borders/Médecins Sans Frontières (MSF), USA “…Today, AARP and Doctors Without Borders/Médecins Sans Frontières (MSF) express our deep concerns about the TPP’s impact on…

Critics Question Effectiveness Of Medicines Patent Pool In Improving Access To Drugs

SciDev.Net: Merck’s HIV patent agreement ignites monopoly criticism “Pharma giant Merck has become the latest drug company to share intellectual property rights with a U.N.-backed patent pool for HIV medicines, but critics have told SciDev.Net it is ‘a false solution to a real problem’…” (Kennedy, 3/16).

U.S. Trade Policies Threaten To Undermine Successful Global Health Programs

The Hill: U.S. trade policy could raise drug prices, at home and abroad Rep. Jan Schakowsky (D-Ill.) and Peter Maybarduk, director of Public Citizen’s Global Access to Medicines program “…[With the creation of PEPFAR, t]he United States put public health needs ahead of pharmaceutical industry profits and made a transformative…

Passage Of ‘Innovation Act’ By Congress Would Harm Drug Development

Roll Call: The Wrong Direction on Patents Todd E. Gillenwater, senior vice president of Public Policy at the California Healthcare Institute “…Poorly conceived and hastily written legislation can stunt innovation, harm the economy, and even cost lives. Unfortunately, this is the case with the recently reintroduced Innovation Act (H.R. 9).…

Pharmaceutical Industry To Push For Stricter Compulsory Licensing Of Patented Drugs At U.S. Trade Representative Meeting

Wall Street Journal: Pharma Narrowly Defines When Compulsory Licenses Should be Used “As the U.S. Trade Representative holds a hearing [Tuesday] to discuss how countries protect intellectual property, the pharmaceutical industry hopes to persuade the agency that countries should only be allowed to grant licenses to companies to make low-cost…

Food Security, Nutrition Should Be Treated As Human Right In SDGs

The Guardian: Why are there still so many hungry people in the world? Hilal Elver, U.N. special rapporteur on the right to food “…The new [Sustainable Development Goals] should not be allowed to operate as easily ignored principles, but need to be given teeth. We can eradicate poverty, maintain food…

Humanosphere Podcast Features Intellectual Property, Patent Expert Jamie Love

Humanosphere: Patently unfair: On the need for more equitable drug pricing In this podcast, Humanosphere contributor Gabe Spitzer of KPLU Public Radio speaks with Jamie Love, director of Knowledge Ecology International, about the organization’s work in intellectual property rights, patent law, and trade agreements (1/16).